The prognostic value of the Charlson’s comorbidity index in patients with bacteremic pneumonia

S. Song (Busan, Republic of Korea), S. Moon (Busan, Republic of Korea), S. Kim (Busan, Republic of Korea), M. Ko (Busan, Republic of Korea), J. Kim (Busan, Republic of Korea)

Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Session: Improving the outcomes of community-acquired pneumonia
Session type: Poster Discussion
Number: 2037
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Song (Busan, Republic of Korea), S. Moon (Busan, Republic of Korea), S. Kim (Busan, Republic of Korea), M. Ko (Busan, Republic of Korea), J. Kim (Busan, Republic of Korea). The prognostic value of the Charlson’s comorbidity index in patients with bacteremic pneumonia. 2037

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic value of the pneumonia severity index (PSI), CURB-65 for young and elderly patients
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Oxy-Met score: a new physiological index to predict mortality in community-acquired pneumonia
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017




Comparison of the predictive rules PSI and CRB-65 for assessing severity of community-acquired pneumonia among patients over 65 years
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010


Prognostic value of the Charlson Comorbidity Index in patient with COPD
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012


Could age-adjusted Charlson comorbidity index predict outcomes in patients submitted to noninvasive ventilation?
Source: International Congress 2017 – Noninvasive ventilation for acute respiratory failure
Year: 2017


CURB-65 scoring utilization in predicting mortality of hospitalized patients with AE-COPD
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012


Comparison of biomarkers and SOFA score prognostic value in ventilator-associated pneumonia
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009



CUR-65 score for community-acquired pneumonia predicted mortality better than CURB-65 score in low-mortality-rate settings
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Impact of age and comorbidity on presentation, aetiology and outcome in patients with community-acquired pneumonia
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012

Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010

CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012


Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007

Correlation between pneumonia severity index and mortality within 30 days after the diagnosis of community-acquired pneumonia in elderly subjects
Source: Eur Respir J 2006; 28: Suppl. 50, 741s
Year: 2006

Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 groups at risk
Source: Eur Respir J 2007; 30: Suppl. 51, 481s
Year: 2007

The index distance-saturation product like predicting of mortality in patients with COPD
Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment
Year: 2008


FEV1/FEV6 index in hospitalized patients with multimorbidity
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

CURB65 versus PSI in assessing the severity of CAP of elderly patients
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010


Prognostic value of procalcitonin in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 384
Year: 2011